vs
Side-by-side financial comparison of IDEAYA Biosciences, Inc. (IDYA) and Vroom, Inc. (VRM). Click either name above to swap in a different company.
Vroom, Inc. is the larger business by last-quarter revenue ($235.9M vs $207.8M, roughly 1.1× IDEAYA Biosciences, Inc.). IDEAYA Biosciences, Inc. runs the higher net margin — 57.4% vs -59.8%, a 117.2% gap on every dollar of revenue. IDEAYA Biosciences, Inc. produced more free cash flow last quarter ($142.2M vs $-108.8M).
IDEAYA Biosciences, Inc. is a clinical-stage biotechnology company focused on oncology, developing targeted therapies and synthetic lethality treatments for patients with genetically defined cancers. It advances a pipeline of candidates across multiple tumor types, partnering with industry stakeholders to accelerate global access to innovative cancer care solutions.
Vroom, Inc. is a parent company of United Auto Credit Corporation (UACC) and CarStory. Previously, Vroom was a used car retailer and e-commerce company that let consumers buy, sell, and finance cars online. Vroom ceased e-commerce automotive sales operations on January 22, 2024.
IDYA vs VRM — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2023
| Metric | | |
|---|---|---|
| Revenue | $207.8M | $235.9M |
| Net Profit | $119.2M | $-141.1M |
| Gross Margin | — | 12.3% |
| Operating Margin | 52.2% | -11.5% |
| Net Margin | 57.4% | -59.8% |
| Revenue YoY | — | 12.9% |
| Net Profit YoY | 330.1% | -669.8% |
| EPS (diluted) | $1.33 | $-80.66 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $207.8M | — | ||
| Q3 24 | $0 | — | ||
| Q2 24 | $0 | — | ||
| Q1 24 | $0 | — | ||
| Q4 23 | — | $235.9M | ||
| Q3 23 | — | $235.6M | ||
| Q2 23 | — | $225.2M | ||
| Q1 23 | — | $196.5M |
| Q3 25 | $119.2M | — | ||
| Q3 24 | $-51.8M | — | ||
| Q2 24 | $-52.8M | — | ||
| Q1 24 | $-39.6M | — | ||
| Q4 23 | — | $-141.1M | ||
| Q3 23 | — | $-82.7M | ||
| Q2 23 | — | $-66.0M | ||
| Q1 23 | — | $-74.7M |
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 12.3% | ||
| Q3 23 | — | 20.4% | ||
| Q2 23 | — | 20.4% | ||
| Q1 23 | — | 19.8% |
| Q3 25 | 52.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -11.5% | ||
| Q3 23 | — | -18.0% | ||
| Q2 23 | — | -23.4% | ||
| Q1 23 | — | -34.7% |
| Q3 25 | 57.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -59.8% | ||
| Q3 23 | — | -35.1% | ||
| Q2 23 | — | -29.3% | ||
| Q1 23 | — | -38.0% |
| Q3 25 | $1.33 | — | ||
| Q3 24 | $-0.60 | — | ||
| Q2 24 | $-0.68 | — | ||
| Q1 24 | $-0.53 | — | ||
| Q4 23 | — | $-80.66 | ||
| Q3 23 | — | $-47.38 | ||
| Q2 23 | — | $-37.97 | ||
| Q1 23 | — | $-43.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $786.9M | $135.6M |
| Total DebtLower is stronger | — | $454.2M |
| Stockholders' EquityBook value | $1.1B | $127.7M |
| Total Assets | $1.2B | $1.5B |
| Debt / EquityLower = less leverage | — | 3.56× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $786.9M | — | ||
| Q3 24 | $920.0M | — | ||
| Q2 24 | $701.7M | — | ||
| Q1 24 | $698.8M | — | ||
| Q4 23 | — | $135.6M | ||
| Q3 23 | — | $208.6M | ||
| Q2 23 | — | $237.9M | ||
| Q1 23 | — | $316.7M |
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $454.2M | ||
| Q3 23 | — | $521.4M | ||
| Q2 23 | — | $544.9M | ||
| Q1 23 | — | $554.7M |
| Q3 25 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $931.7M | — | ||
| Q1 24 | $935.3M | — | ||
| Q4 23 | — | $127.7M | ||
| Q3 23 | — | $263.6M | ||
| Q2 23 | — | $343.4M | ||
| Q1 23 | — | $407.1M |
| Q3 25 | $1.2B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $973.7M | — | ||
| Q1 24 | $961.5M | — | ||
| Q4 23 | — | $1.5B | ||
| Q3 23 | — | $1.6B | ||
| Q2 23 | — | $1.6B | ||
| Q1 23 | — | $1.7B |
| Q3 25 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 3.56× | ||
| Q3 23 | — | 1.98× | ||
| Q2 23 | — | 1.59× | ||
| Q1 23 | — | 1.36× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.2M | $-108.1M |
| Free Cash FlowOCF − Capex | $142.2M | $-108.8M |
| FCF MarginFCF / Revenue | 68.4% | -46.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | 1.19× | — |
| TTM Free Cash FlowTrailing 4 quarters | $13.5M | $-536.3M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $142.2M | — | ||
| Q3 24 | $-49.2M | — | ||
| Q2 24 | $-32.9M | — | ||
| Q1 24 | $-43.8M | — | ||
| Q4 23 | — | $-108.1M | ||
| Q3 23 | — | $-193.5M | ||
| Q2 23 | — | $-147.1M | ||
| Q1 23 | — | $-85.0M |
| Q3 25 | $142.2M | — | ||
| Q3 24 | $-49.7M | — | ||
| Q2 24 | $-33.9M | — | ||
| Q1 24 | $-45.1M | — | ||
| Q4 23 | — | $-108.8M | ||
| Q3 23 | — | $-194.2M | ||
| Q2 23 | — | $-147.5M | ||
| Q1 23 | — | $-85.8M |
| Q3 25 | 68.4% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | -46.1% | ||
| Q3 23 | — | -82.4% | ||
| Q2 23 | — | -65.5% | ||
| Q1 23 | — | -43.7% |
| Q3 25 | 0.0% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 0.3% | ||
| Q3 23 | — | 0.3% | ||
| Q2 23 | — | 0.2% | ||
| Q1 23 | — | 0.4% |
| Q3 25 | 1.19× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
